Treatment of AMs with ARDS BAL increased expression of CD206 (Figure 3A, mean fold change 0.39, p = 0.006) and MerTK (Figure 3B, mean fold change 0.3, p = 0.028) compared to VC treatment. This evidence concerns the gene MERTK and acute respiratory distress syndrome.